96 related articles for article (PubMed ID: 29672466)
1. A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer.
Borakati A; Razack A; Cawthorne C; Roy R; Usmani S; Ahmed N
Nucl Med Commun; 2018 Jul; 39(7):628-635. PubMed ID: 29672466
[TBL] [Abstract][Full Text] [Related]
2. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
Malik V; Johnston C; O'Toole D; Lucey J; O'Farrell N; Claxton Z; Reynolds JV
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27862622
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.
Dellaportas D; Zylstra J; Gossage J; Baker C; Kelly M; Hemelrijck MV; Griffin N; Lagergren J; Davies AR
Chirurgia (Bucur); 2019; 114(4):443-450. PubMed ID: 31511130
[No Abstract] [Full Text] [Related]
4. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
[TBL] [Abstract][Full Text] [Related]
6. Impact of Endoscopic Ultrasonography on
Hulshoff JB; Mul VEM; de Boer HEM; Noordzij W; Korteweg T; van Dullemen HM; Nagengast WB; Oppedijk V; Pierie JPEN; Plukker JTM
Ann Surg Oncol; 2017 Jul; 24(7):1828-1834. PubMed ID: 28303427
[TBL] [Abstract][Full Text] [Related]
7. PET-CT offers accurate assessment of tumour length in oesophageal malignancy.
Rollins KE; Lucas E; Tewari N; James E; Hughes S; Catton JA
Eur J Radiol; 2015 Feb; 84(2):195-200. PubMed ID: 25435270
[TBL] [Abstract][Full Text] [Related]
8.
Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
[TBL] [Abstract][Full Text] [Related]
9. Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
Reyhani A; Gimson E; Baker C; Kelly M; Maisey N; Meenan J; Subesinghe M; Hill M; Lagergren J; Gossage J; Zeki S; Dunn J; Davies A
Dis Esophagus; 2023 Sep; 36(10):. PubMed ID: 37032121
[TBL] [Abstract][Full Text] [Related]
10. Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer.
Foley KG; Morgan C; Roberts SA; Crosby T
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):760-766. PubMed ID: 28818538
[TBL] [Abstract][Full Text] [Related]
11. Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
Bjerring OS; Hess S; Petersen H; Fristrup CW; Lundell L; Mortensen MB
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688946
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
13. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Findlay JM; Bradley KM; Maile EJ; Braden B; Maw J; Phillips-Hughes J; Gillies RS; Maynard ND; Middleton MR
Br J Surg; 2015 Nov; 102(12):1488-99. PubMed ID: 26458070
[TBL] [Abstract][Full Text] [Related]
14. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
[TBL] [Abstract][Full Text] [Related]
16. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR
Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886
[TBL] [Abstract][Full Text] [Related]
17. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy volume delineation based on (
Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U
Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658
[TBL] [Abstract][Full Text] [Related]
19. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
